HEADER HYDROLASE/HYDROLASE INHIBITOR 25-MAR-21 7M63 TITLE CRYSTAL STRUCTURE OF THE INDOLEAMINE 2,3-DIOXYGENAGSE 1 (IDO1) TITLE 2 COMPLEXED WITH IACS-70099 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE; COMPND 5 EC: 1.13.11.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IDO1, IDO, INDO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS IDO1, INHIBITOR, ENZYME, COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.G.LEONARD,J.B.CROSS REVDAT 2 18-OCT-23 7M63 1 REMARK REVDAT 1 01-SEP-21 7M63 0 JRNL AUTH M.M.HAMILTON,F.MSEEH,T.J.MCAFOOS,P.G.LEONARD,N.J.REYNA, JRNL AUTH 2 A.L.HARRIS,A.XU,M.HAN,M.J.SOTH,B.CZAKO,J.P.THEROFF, JRNL AUTH 3 P.K.MANDAL,J.P.BURKE,B.VIRGIN-DOWNEY,A.PETROCCHI, JRNL AUTH 4 D.PFAFFINGER,N.E.ROGERS,C.A.PARKER,S.S.YU,Y.JIANG,S.KRAPP, JRNL AUTH 5 A.LAMMENS,G.TREVITT,M.R.TREMBLAY,K.MIKULE,K.WILCOXEN, JRNL AUTH 6 J.B.CROSS,P.JONES,J.R.MARSZALEK,R.T.LEWIS JRNL TITL DISCOVERY OF IACS-9779 AND IACS-70465 AS POTENT INHIBITORS JRNL TITL 2 TARGETING INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) APOENZYME. JRNL REF J.MED.CHEM. V. 64 11302 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34292726 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00679 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 18394 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 917 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 52.6300 - 5.9300 0.98 2645 155 0.1789 0.1952 REMARK 3 2 5.9300 - 4.7100 0.99 2570 112 0.2102 0.2408 REMARK 3 3 4.7100 - 4.1100 0.99 2523 136 0.2016 0.2527 REMARK 3 4 4.1100 - 3.7400 0.98 2465 140 0.2657 0.3307 REMARK 3 5 3.7400 - 3.4700 0.98 2479 126 0.3288 0.3704 REMARK 3 6 3.4700 - 3.2600 0.97 2446 122 0.3741 0.4355 REMARK 3 7 3.2600 - 3.1000 0.93 2349 126 0.4723 0.5049 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.821 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 38.147 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 6068 REMARK 3 ANGLE : 0.511 8218 REMARK 3 CHIRALITY : 0.038 908 REMARK 3 PLANARITY : 0.005 1044 REMARK 3 DIHEDRAL : 4.241 797 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7M63 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255646. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.2.2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18604 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 52.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 13.80 REMARK 200 R MERGE (I) : 0.51100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 13.40 REMARK 200 R MERGE FOR SHELL (I) : 3.53300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.1 REMARK 200 STARTING MODEL: 5ETW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8.0, 18% (W/V) PEG6000, REMARK 280 0.2 M NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.45500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.14500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.03500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.14500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.45500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.03500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 SER A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 LEU A 3 REMARK 465 VAL A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 HIS A 9 REMARK 465 MET A 10 REMARK 465 GLN A 361 REMARK 465 PRO A 362 REMARK 465 LYS A 363 REMARK 465 GLU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 THR A 367 REMARK 465 SER A 368 REMARK 465 GLU A 369 REMARK 465 ASP A 370 REMARK 465 PRO A 371 REMARK 465 SER A 372 REMARK 465 LYS A 373 REMARK 465 LEU A 374 REMARK 465 GLU A 375 REMARK 465 ALA A 376 REMARK 465 LYS A 377 REMARK 465 GLY A 378 REMARK 465 THR A 379 REMARK 465 GLY A 380 REMARK 465 LYS A 401 REMARK 465 GLU A 402 REMARK 465 GLY A 403 REMARK 465 MET B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 SER B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 LEU B 3 REMARK 465 VAL B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 HIS B 9 REMARK 465 MET B 10 REMARK 465 ILE B 11 REMARK 465 GLN B 360 REMARK 465 GLN B 361 REMARK 465 PRO B 362 REMARK 465 LYS B 363 REMARK 465 GLU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 THR B 367 REMARK 465 SER B 368 REMARK 465 GLU B 369 REMARK 465 ASP B 370 REMARK 465 PRO B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 LEU B 374 REMARK 465 GLU B 375 REMARK 465 ALA B 376 REMARK 465 LYS B 377 REMARK 465 GLY B 378 REMARK 465 THR B 379 REMARK 465 GLY B 380 REMARK 465 GLU B 402 REMARK 465 GLY B 403 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 13 -131.24 -94.44 REMARK 500 GLU A 14 45.35 -86.57 REMARK 500 ASN A 27 76.23 52.07 REMARK 500 TYR A 36 49.08 -102.19 REMARK 500 VAL A 130 -47.30 -134.41 REMARK 500 PHE A 154 -68.42 -105.14 REMARK 500 VAL A 229 -60.83 -100.07 REMARK 500 TRP A 237 57.33 -140.20 REMARK 500 PHE A 252 -46.58 -142.53 REMARK 500 ILE A 354 -58.16 -121.81 REMARK 500 ASN B 27 74.79 55.54 REMARK 500 TYR B 36 38.81 -88.19 REMARK 500 THR B 71 -70.48 -96.58 REMARK 500 ASP B 98 94.84 -68.94 REMARK 500 VAL B 130 -49.45 -132.23 REMARK 500 ASN B 133 57.36 -117.27 REMARK 500 PHE B 154 -60.09 -106.55 REMARK 500 VAL B 229 -63.35 -106.16 REMARK 500 LEU B 243 74.51 -118.52 REMARK 500 PHE B 252 -36.20 -148.74 REMARK 500 REMARK 500 REMARK: NULL DBREF 7M63 A 11 403 UNP P14902 I23O1_HUMAN 11 403 DBREF 7M63 B 11 403 UNP P14902 I23O1_HUMAN 11 403 SEQADV 7M63 MET A -7 UNP P14902 INITIATING METHIONINE SEQADV 7M63 HIS A -6 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A -5 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A -4 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A -3 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A -2 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A -1 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER A 0 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER A 1 UNP P14902 EXPRESSION TAG SEQADV 7M63 GLY A 2 UNP P14902 EXPRESSION TAG SEQADV 7M63 LEU A 3 UNP P14902 EXPRESSION TAG SEQADV 7M63 VAL A 4 UNP P14902 EXPRESSION TAG SEQADV 7M63 PRO A 5 UNP P14902 EXPRESSION TAG SEQADV 7M63 ARG A 6 UNP P14902 EXPRESSION TAG SEQADV 7M63 GLY A 7 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER A 8 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS A 9 UNP P14902 EXPRESSION TAG SEQADV 7M63 MET A 10 UNP P14902 EXPRESSION TAG SEQADV 7M63 MET B -7 UNP P14902 INITIATING METHIONINE SEQADV 7M63 HIS B -6 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B -5 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B -4 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B -3 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B -2 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B -1 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER B 0 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER B 1 UNP P14902 EXPRESSION TAG SEQADV 7M63 GLY B 2 UNP P14902 EXPRESSION TAG SEQADV 7M63 LEU B 3 UNP P14902 EXPRESSION TAG SEQADV 7M63 VAL B 4 UNP P14902 EXPRESSION TAG SEQADV 7M63 PRO B 5 UNP P14902 EXPRESSION TAG SEQADV 7M63 ARG B 6 UNP P14902 EXPRESSION TAG SEQADV 7M63 GLY B 7 UNP P14902 EXPRESSION TAG SEQADV 7M63 SER B 8 UNP P14902 EXPRESSION TAG SEQADV 7M63 HIS B 9 UNP P14902 EXPRESSION TAG SEQADV 7M63 MET B 10 UNP P14902 EXPRESSION TAG SEQRES 1 A 411 MET HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO SEQRES 2 A 411 ARG GLY SER HIS MET ILE SER LYS GLU TYR HIS ILE ASP SEQRES 3 A 411 GLU GLU VAL GLY PHE ALA LEU PRO ASN PRO GLN GLU ASN SEQRES 4 A 411 LEU PRO ASP PHE TYR ASN ASP TRP MET PHE ILE ALA LYS SEQRES 5 A 411 HIS LEU PRO ASP LEU ILE GLU SER GLY GLN LEU ARG GLU SEQRES 6 A 411 ARG VAL GLU LYS LEU ASN MET LEU SER ILE ASP HIS LEU SEQRES 7 A 411 THR ASP HIS LYS SER GLN ARG LEU ALA ARG LEU VAL LEU SEQRES 8 A 411 GLY CYS ILE THR MET ALA TYR VAL TRP GLY LYS GLY HIS SEQRES 9 A 411 GLY ASP VAL ARG LYS VAL LEU PRO ARG ASN ILE ALA VAL SEQRES 10 A 411 PRO TYR CYS GLN LEU SER LYS LYS LEU GLU LEU PRO PRO SEQRES 11 A 411 ILE LEU VAL TYR ALA ASP CYS VAL LEU ALA ASN TRP LYS SEQRES 12 A 411 LYS LYS ASP PRO ASN LYS PRO LEU THR TYR GLU ASN MET SEQRES 13 A 411 ASP VAL LEU PHE SER PHE ARG ASP GLY ASP CYS SER LYS SEQRES 14 A 411 GLY PHE PHE LEU VAL SER LEU LEU VAL GLU ILE ALA ALA SEQRES 15 A 411 ALA SER ALA ILE LYS VAL ILE PRO THR VAL PHE LYS ALA SEQRES 16 A 411 MET GLN MET GLN GLU ARG ASP THR LEU LEU LYS ALA LEU SEQRES 17 A 411 LEU GLU ILE ALA SER CYS LEU GLU LYS ALA LEU GLN VAL SEQRES 18 A 411 PHE HIS GLN ILE HIS ASP HIS VAL ASN PRO LYS ALA PHE SEQRES 19 A 411 PHE SER VAL LEU ARG ILE TYR LEU SER GLY TRP LYS GLY SEQRES 20 A 411 ASN PRO GLN LEU SER ASP GLY LEU VAL TYR GLU GLY PHE SEQRES 21 A 411 TRP GLU ASP PRO LYS GLU PHE ALA GLY GLY SER ALA GLY SEQRES 22 A 411 GLN SER SER VAL PHE GLN CYS PHE ASP VAL LEU LEU GLY SEQRES 23 A 411 ILE GLN GLN THR ALA GLY GLY GLY HIS ALA ALA GLN PHE SEQRES 24 A 411 LEU GLN ASP MET ARG ARG TYR MET PRO PRO ALA HIS ARG SEQRES 25 A 411 ASN PHE LEU CYS SER LEU GLU SER ASN PRO SER VAL ARG SEQRES 26 A 411 GLU PHE VAL LEU SER LYS GLY ASP ALA GLY LEU ARG GLU SEQRES 27 A 411 ALA TYR ASP ALA CYS VAL LYS ALA LEU VAL SER LEU ARG SEQRES 28 A 411 SER TYR HIS LEU GLN ILE VAL THR LYS TYR ILE LEU ILE SEQRES 29 A 411 PRO ALA SER GLN GLN PRO LYS GLU ASN LYS THR SER GLU SEQRES 30 A 411 ASP PRO SER LYS LEU GLU ALA LYS GLY THR GLY GLY THR SEQRES 31 A 411 ASP LEU MET ASN PHE LEU LYS THR VAL ARG SER THR THR SEQRES 32 A 411 GLU LYS SER LEU LEU LYS GLU GLY SEQRES 1 B 411 MET HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO SEQRES 2 B 411 ARG GLY SER HIS MET ILE SER LYS GLU TYR HIS ILE ASP SEQRES 3 B 411 GLU GLU VAL GLY PHE ALA LEU PRO ASN PRO GLN GLU ASN SEQRES 4 B 411 LEU PRO ASP PHE TYR ASN ASP TRP MET PHE ILE ALA LYS SEQRES 5 B 411 HIS LEU PRO ASP LEU ILE GLU SER GLY GLN LEU ARG GLU SEQRES 6 B 411 ARG VAL GLU LYS LEU ASN MET LEU SER ILE ASP HIS LEU SEQRES 7 B 411 THR ASP HIS LYS SER GLN ARG LEU ALA ARG LEU VAL LEU SEQRES 8 B 411 GLY CYS ILE THR MET ALA TYR VAL TRP GLY LYS GLY HIS SEQRES 9 B 411 GLY ASP VAL ARG LYS VAL LEU PRO ARG ASN ILE ALA VAL SEQRES 10 B 411 PRO TYR CYS GLN LEU SER LYS LYS LEU GLU LEU PRO PRO SEQRES 11 B 411 ILE LEU VAL TYR ALA ASP CYS VAL LEU ALA ASN TRP LYS SEQRES 12 B 411 LYS LYS ASP PRO ASN LYS PRO LEU THR TYR GLU ASN MET SEQRES 13 B 411 ASP VAL LEU PHE SER PHE ARG ASP GLY ASP CYS SER LYS SEQRES 14 B 411 GLY PHE PHE LEU VAL SER LEU LEU VAL GLU ILE ALA ALA SEQRES 15 B 411 ALA SER ALA ILE LYS VAL ILE PRO THR VAL PHE LYS ALA SEQRES 16 B 411 MET GLN MET GLN GLU ARG ASP THR LEU LEU LYS ALA LEU SEQRES 17 B 411 LEU GLU ILE ALA SER CYS LEU GLU LYS ALA LEU GLN VAL SEQRES 18 B 411 PHE HIS GLN ILE HIS ASP HIS VAL ASN PRO LYS ALA PHE SEQRES 19 B 411 PHE SER VAL LEU ARG ILE TYR LEU SER GLY TRP LYS GLY SEQRES 20 B 411 ASN PRO GLN LEU SER ASP GLY LEU VAL TYR GLU GLY PHE SEQRES 21 B 411 TRP GLU ASP PRO LYS GLU PHE ALA GLY GLY SER ALA GLY SEQRES 22 B 411 GLN SER SER VAL PHE GLN CYS PHE ASP VAL LEU LEU GLY SEQRES 23 B 411 ILE GLN GLN THR ALA GLY GLY GLY HIS ALA ALA GLN PHE SEQRES 24 B 411 LEU GLN ASP MET ARG ARG TYR MET PRO PRO ALA HIS ARG SEQRES 25 B 411 ASN PHE LEU CYS SER LEU GLU SER ASN PRO SER VAL ARG SEQRES 26 B 411 GLU PHE VAL LEU SER LYS GLY ASP ALA GLY LEU ARG GLU SEQRES 27 B 411 ALA TYR ASP ALA CYS VAL LYS ALA LEU VAL SER LEU ARG SEQRES 28 B 411 SER TYR HIS LEU GLN ILE VAL THR LYS TYR ILE LEU ILE SEQRES 29 B 411 PRO ALA SER GLN GLN PRO LYS GLU ASN LYS THR SER GLU SEQRES 30 B 411 ASP PRO SER LYS LEU GLU ALA LYS GLY THR GLY GLY THR SEQRES 31 B 411 ASP LEU MET ASN PHE LEU LYS THR VAL ARG SER THR THR SEQRES 32 B 411 GLU LYS SER LEU LEU LYS GLU GLY HET YRP A 501 29 HET YRP B 501 29 HETNAM YRP (2R)-N-(4-CHLOROPHENYL)-2-[(1R,3S,5S,6R)-3-(5,6- HETNAM 2 YRP DIFLUORO-1H-BENZIMIDAZOL-1-YL)BICYCLO[3.1.0]HEXAN-6- HETNAM 3 YRP YL]PROPANAMIDE FORMUL 3 YRP 2(C22 H20 CL F2 N3 O) HELIX 1 AA1 PRO A 33 PHE A 35 5 3 HELIX 2 AA2 TYR A 36 HIS A 45 1 10 HELIX 3 AA3 HIS A 45 GLY A 53 1 9 HELIX 4 AA4 GLN A 54 LYS A 61 1 8 HELIX 5 AA5 ASP A 72 GLY A 93 1 22 HELIX 6 AA6 PRO A 104 LEU A 118 1 15 HELIX 7 AA7 VAL A 125 VAL A 130 1 6 HELIX 8 AA8 THR A 144 GLU A 146 5 3 HELIX 9 AA9 CYS A 159 LYS A 179 1 21 HELIX 10 AB1 VAL A 180 MET A 190 1 11 HELIX 11 AB2 GLU A 192 HIS A 215 1 24 HELIX 12 AB3 GLN A 216 VAL A 221 1 6 HELIX 13 AB4 ASN A 222 VAL A 229 1 8 HELIX 14 AB5 VAL A 229 SER A 235 1 7 HELIX 15 AB6 SER A 263 GLN A 266 5 4 HELIX 16 AB7 SER A 267 LEU A 277 1 11 HELIX 17 AB8 GLY A 286 MET A 295 1 10 HELIX 18 AB9 PRO A 300 ASN A 313 1 14 HELIX 19 AC1 SER A 315 GLY A 324 1 10 HELIX 20 AC2 ASP A 325 ILE A 354 1 30 HELIX 21 AC3 ILE A 354 SER A 359 1 6 HELIX 22 AC4 THR A 382 LYS A 397 1 16 HELIX 23 AC5 SER B 12 HIS B 16 5 5 HELIX 24 AC6 PRO B 33 PHE B 35 5 3 HELIX 25 AC7 TYR B 36 HIS B 45 1 10 HELIX 26 AC8 HIS B 45 SER B 52 1 8 HELIX 27 AC9 GLN B 54 LYS B 61 1 8 HELIX 28 AD1 SER B 66 LEU B 70 5 5 HELIX 29 AD2 ASP B 72 GLY B 93 1 22 HELIX 30 AD3 PRO B 104 LEU B 118 1 15 HELIX 31 AD4 VAL B 125 VAL B 130 1 6 HELIX 32 AD5 THR B 144 GLU B 146 5 3 HELIX 33 AD6 CYS B 159 LYS B 179 1 21 HELIX 34 AD7 VAL B 180 GLN B 191 1 12 HELIX 35 AD8 GLU B 192 HIS B 215 1 24 HELIX 36 AD9 GLN B 216 VAL B 221 1 6 HELIX 37 AE1 ASN B 222 SER B 228 1 7 HELIX 38 AE2 VAL B 229 SER B 235 1 7 HELIX 39 AE3 SER B 263 GLN B 266 5 4 HELIX 40 AE4 SER B 267 LEU B 277 1 11 HELIX 41 AE5 GLY B 286 MET B 295 1 10 HELIX 42 AE6 ARG B 296 MET B 299 5 4 HELIX 43 AE7 PRO B 300 ASN B 313 1 14 HELIX 44 AE8 SER B 315 GLY B 324 1 10 HELIX 45 AE9 ASP B 325 ILE B 354 1 30 HELIX 46 AF1 ILE B 354 SER B 359 1 6 HELIX 47 AF2 THR B 382 LYS B 397 1 16 SHEET 1 AA1 2 VAL A 102 LEU A 103 0 SHEET 2 AA1 2 VAL A 248 TYR A 249 1 O VAL A 248 N LEU A 103 SHEET 1 AA2 2 LYS A 135 LYS A 136 0 SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135 SHEET 1 AA3 2 VAL B 102 LEU B 103 0 SHEET 2 AA3 2 VAL B 248 TYR B 249 1 O VAL B 248 N LEU B 103 SHEET 1 AA4 2 LYS B 135 LYS B 136 0 SHEET 2 AA4 2 MET B 148 ASP B 149 -1 O ASP B 149 N LYS B 135 SSBOND 1 CYS A 308 CYS B 308 1555 1555 2.03 CRYST1 84.910 92.070 128.290 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011777 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010861 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007795 0.00000